HealthTree Logo
search more_vert
close
person Sign In / Create Account
Hot immunotherapy work using CAR T cells for a common myeloma target with Dr. Craig Hofmeister, MD, OSU
Hot immunotherapy work using CAR T cells for a common myeloma target with Dr. Craig Hofmeister, MD, OSU image
HealthTree Podcast for Multiple Myeloma
event Mar 30, 2015 / 11:00AM MDT

Event Description

In our first MCRI episode featuring the top 10 proposals for high-risk multiple myeloma, Dr. Craig Hofmeister shares his work to use the hot-topic CAR T cell approach to target a common myeloma protein, CS1. He describes that the discovery of elotuzumab helped determine that CS1 was an effective target. For this approach, CAR T cells are withdrawn from the patient, re-engineered to target the CS1 protein and then are placed back into the patient's system. Once inside, the CAR T cells replicate, target the cells that express that CS1 protein and essentially blow themselves up. He notes that CS1 was a target that was found on myeloma cells but not on many other cells in the body, making it an attractive target. It is a one-time therapy that is appropriate not only for patients with high-risk myeloma but all types of myeloma regardless of genetic features. In time, it could also be used as a preventative approach for smoldering patients. He addresses the promise of this up and coming approach and also addresses the potential safety issues of this type of therapy. This approach is not far from in-human clinical trials. 

Takeda-5x3-towel-logo

Schedule & Agenda

person
Discussion
11:00AM
Dr. Craig Hofmeister, MD and Jenny Ahlstrom

Speakers & Moderators

The panelist Craig Hofmeister
Craig Hofmeister

Craig C. Hofmeister, MD, MPH, is Professor in the Department of Hematology and Medical Oncology at Emory University School of Medicine. Board certified in internal medicine and hematology, Dr. Hofmeister’s practice focuses on plasma cell cancers, including plasmacytomas, multiple myeloma, AL amyloidosis, smoldering myeloma, and monoclonal gammopathies of renal significance. He started practicing with Emory Healthcare in 2018.

Read Bio
The panelist Jennifer Ahlstrom
Jennifer Ahlstrom

Myeloma survivor, patient advocate, wife, mom of 6. Believer that patients can help accelerate a cure by weighing in and participating in clinical research. Founder of the HealthTree Foundation.

Read Bio

Have Any Questions?

Thank you for your interest in the event. If you have any questions, we would love to help!

Feel free to give us a call or send us a message below.

support

Get In Touch With Us

phone

1-800-709-1113

email

Support@healthtree.org

Get the latest thought leadership on Multiple Myeloma delivered straight to your inbox.

Subscribe to the weekly "HealthTree Community for Multiple Myeloma Newsletter" for Multiple Myeloma news, life with Multiple Myeloma stories, Multiple Myeloma clinical trials, Multiple Myeloma 101 articles and events with Multiple Myeloma experts.

Thanks to our HealthTree Community for Multiple Myeloma Sponsors:

Johnson and Johnson
Sanofi
Pfizer
Regeneron
Adaptive
Bristol Myers Squibb

Follow Us

facebook instagram linkedin tiktok youtube